Impact of HMGB1 binding on the structural alterations of platinum drug-treated single dsDNA molecule

• Published in: Biochimie 2023-10, Vol.213, p.168-175
• Main Authors: Mondal, Sourav, Banerjee, Siddhartha, Dey, Debapriya, Lahiri, Hiya, Mana, Tanushree, Jana, Siddhartha S., Mukhopadhyay, Rupa
• Format: Article
• Language: English
• Subjects: AFM-based force spectroscopy; DNA stiffness; HMGB1; Platinum anticancer drug; single DNA molecule; Young’s modulus
• ISSN: 0300-9084; 1638-6183
• DOI: 10.1016/j.biochi.2023.05.012

High mobility group B1 (HMGB1) is an architectural protein that recognizes the DNA damage sites formed by the platinum anticancer drugs. However, the impact of HMGB1 binding on the structural alterations of the platinum drug-treated single dsDNA molecules has remained largely unknown. Herein, the structural alterations induced by the platinum drugs, the mononuclear cisplatin and it's analog the trinuclear BBR3464, have been probed in presence of HMGB1, by atomic force microscopy (AFM) and AFM-based force spectroscopy. It is observed that the drug-induced DNA loop formation enhanced upon HMGB1 binding, most likely as a result of HMGB1-induced increase in DNA conformational flexibility that allowed the drug-binding sites to come close and form double adducts, thereby resulting in enhanced loop formation via inter-helix cross-linking. Since HMGB1 enhances DNA flexibility, the near-reversible structural transitions as observed in the force-extension curves (for 1 h drug treatment), generally occurred at lower forces in presence of HMGB1. The DNA structural integrity was largely lost after 24 h drug treatment as no reversible transition could be observed. The Young's modulus of the dsDNA molecules, as estimated from the force-extension analysis, increased upon drug treatment, due to formation of the drug-induced covalent cross-links and consequent reduction in DNA flexibility. The Young's modulus increased further in presence of HMGB1 due to HMGB1-induced enhancement in DNA flexibility that could ease formation of the drug-induced covalent cross-links. To our knowledge, this is the first report that shows an increase in the stiffness of the platinum drug-treated DNA molecules in presence of HMGB1. •HMGB1 enhances loop formation in platinum anticancer drug-treated DNA.•DNA stiffness increases upon treatment with platinum anticancer drugs.•HMGB1 further increases stiffness of the platinum anticancer drug-treated DNA.